Development Committee

Our project facilitators help to advocate projects for philanthropic investments in addition to the in-house development and philanthropy team members at HAMRC and Hadassah Australia.

Dug Pomeroy - Chair

Dug Pomeroy is the founder and Executive Chairman of Pomeroy Pacific Pty Ltd. Founded in 1971, the Pomeroy Group of Companies has an extensive background in Development Services, Project Management, Construction Management and Property Investment.

Jacqueline Pascarl

Jacqueline Pascarl is a multi-lingual, high-profile expert consultant who served five years as the first female National Vice Chair of the Australian Defence Forces (Reserves) Executive. She is an award-winning documentary producer and prominent lobbyist on human rights, women’s rights, and refugee issues. Jacqueline has raised over $40 million for the NFP sector.

Dr Phillip Brenner

Dr Phillip Brenner was previously head of St Vincents urology unit in Sydney, New South Wales. A practicing urological surgeon for well over 20 years, Dr. Brenner specialized in treating patients with urological cancers, with a particular emphasis on treating cancer of the prostate as well as cancer of the kidneys.

Alan Liddle

Alan Liddle has over 30 years' experience in developing and commercialising medical and biological therapeutics and over 30 years’ research & executive management experience in the medical and the biotechnology research sector encompassing immunology and bio-therapeutics for cancer and auto-immune diseases, cardiology, neuroplasticity, the microbiome, regenerative medicine & rehabilitation.

Peter Marks

Peter brings over 30 years’ experience in corporate advisory, investment banking and director/advisory roles to the committee. With several leading firms, Peter’s corporate skills lie in capital raising for pre-IPO and listed companies, cross border M&A transactions, corporate underwriting, and venture capital transactions for companies in Australia, US & Israel.

Latest

Stable Glucose Levels Prolong Life for Diabetics, Hadassah Study Finds

A Hadassah Medical Organization study reveals that adults with diabetes whose glucose levels fluctuate over the course of five years have an increased risk of mortality compared with those whose levels remain stable.
Hadassah Develops its own CAR T Therapy to Treat Multiple Myeloma

“Many of the hospital staff treating me used to be my patients. Now my life is in their hands,” relates Hadassah Medical Organization social worker Tali Rosen. Since Rosen’s job as a Hadassah social worker was a challenging one, she waved away the initial tiredness and aching bones she experienced. When repeated infections became more than a nuisance, she had herself tested. Rosen was diagnosed with multiple myeloma, cancer within the spongy bone marrow.
HADASSAH INTERNATIONAL ANNUAL REPORT 2020 – TOGETHER WE LIVE

We are pleased to share with you Hadassah International’s second Annual Report/Year In Review, available in digital format, entitled “Hadassah International – Together We Live”.
From Hidden Child During the Holocaust to Hadassah Surgeon

Dr Shaul Perlberg, age 80, is still practising urology at Hadassah Hospital Mount Scopus, as he has for many years. But it wasn’t until 16 years ago that he decided to reveal the incredible story of his childhood, the reunion with his mother after the Holocaust, their move to Israel, and the way he met the love of his life, Raya.

Dr Phillip Brenner
Dr Errol Katz
Alan Liddle
About us

The HAMRC Foundation is a bold new initiative – a multi-centred collaborative research model that brings together the brightest minds from Israel’s Hadassah Hospital and leading research institutions in Australia and internationally to solve some of the most intractable health problems facing the world today.
Research partnerships

In Hadassah Australia's journey to expand research partnerships, we have collaborated with leading Australian health organisations.
Dug Pomeroy
Prof Jeffrey Zajac AO
Ron Finkel AM
Get involved
Partnering with Israel

With every dollar invested in medical research, Australia gains a $3.90 return to the economy. Many countries competing with Australia have increased their investment. Israel currently has the highest spend globally at 4.25 per cent – thus is a powerful partner for research and development. There are other synergies between our countries including a well-known history of collaboration leading to successful outcomes, medically and commercially.